Sonoma Pharmaceuticals (SNOA) Total Debt (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Total Debt of $222000.0 for Q1 2026, up 0.91% year-over-year from $220000.0 in Q1 2025, and up 296.43% quarter-over-quarter from $56000.0 in Q3 2025.
Sonoma Pharmaceuticals (SNOA) Total Debt (2011 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Total Debt history runs 16 years deep, the most recent figure standing at $222000.0 for Q1 2026.
- In Q1 2026, Total Debt rose 0.91% year-over-year to $222000.0; the TTM figure through Mar 2026 stood at $222000.0 (up 0.91% YoY), while the FY2026 annual figure was $222000.0, up 0.91% from the prior year.
- Total Debt for Q1 2026 stood at $222000.0, up from $56000.0 in the prior quarter.
- The five-year high for Total Debt was $688000.0 in Q1 2022, with the low at $15000.0 in Q4 2022.
- The 5-year median for Total Debt is $220000.0 (2025), against an average of $241000.0.
- The sharpest annual moves came in 2022 and 2023: Total Debt sank 97.44% in 2022, then soared 193.33% in 2023.
- Sonoma Pharmaceuticals' Total Debt stood at $15000.0 in 2022, then surged by 193.33% to $44000.0 in 2023, then jumped by 86.36% to $82000.0 in 2024, then tumbled by 31.71% to $56000.0 in 2025, then jumped by 296.43% to $222000.0 in 2026.
- Business Quant data shows SNOA's Total Debt at $222000.0 in Q1 2026, $56000.0 in Q3 2025, and $139000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 760.00 Mn |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 140,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 140,000.00 |
| Mar 31, 2026 | 222,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 220,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 204,000.00 |
| Mar 31, 2024 | 323,000.00 |
| Dec 31, 2023 | 44,000.00 |
| Sep 30, 2023 | 172,000.00 |
| Jun 30, 2023 | 301,000.00 |
| Mar 31, 2023 | 431,000.00 |
| Dec 31, 2022 | 15,000.00 |
| Sep 30, 2022 | 244,000.00 |
| Jun 30, 2022 | 474,000.00 |
| Mar 31, 2022 | 688,000.00 |
| Dec 31, 2021 | 587,000.00 |
| Sep 30, 2021 | 587,000.00 |
| Jun 30, 2021 | 1.31 Mn |
| Mar 31, 2021 | 1.91 Mn |